Last updated: March 7, 2026
Overview of Patent PL2514464
Patent PL2514464, filed by XYZ Pharma in 2014, covers a novel pharmaceutical compound aimed at treating inflammatory conditions. The patent was granted in Poland in 2019, with a patent term expiry scheduled for 2034, assuming maintenance payments are kept current.
The patent's primary claim covers a compound with a specific chemical structure, including a unique substitution pattern designed to enhance efficacy and reduce side effects. It also includes secondary claims covering methods of synthesis, formulations, and therapeutic applications.
Scope of Patent Claims
Main Claims
- Compound Composition: The patent claims a chemical compound characterized by a specified core structure with defined substitutions at particular positions (see Appendix A for chemical structure).
- Therapeutic Use: The patent insulates methods for treating inflammatory diseases, including rheumatoid arthritis and Crohn's disease, using the compound.
- Manufacturing Method: Claims cover specific synthesis routes that produce the compound with high purity.
- Formulation Claims: The patent claims pharmaceutical compositions including the compound, with particular excipients, dosages, and delivery methods.
Claim Coverage Analysis
| Claim Type |
Coverage Details |
Limitations |
| Compound Structure |
Specific substitution patterns at positions X, Y, Z; chemical stability parameters; stereochemistry considerations. |
Scope limited to compounds matching exact structures. |
| Therapeutic Methods |
Methods of administration for inflammatory diseases. |
Only applicable if using compounds within the claimed structure. |
| Manufacturing Processes |
Synthesis steps involving particular reagents and conditions. |
Valid for processes described; not broad manufacturing patents. |
| Formulations |
Dosage forms (tablets, injections), excipient combinations, release profiles. |
Specific to claimed formulations; does not cover other delivery methods. |
Potential Limitations and Risks
- Novelty: The core structure is innovative but may be challenged if prior art exists showing similar compounds or synthesis methods.
- Inventive Step: The patent’s novelty relies on unique substitution patterns; prior ART with similar scaffolds could impact patent strength.
- Claim Breadth: The claims focus tightly on a specific chemical structure, risking narrow coverage if minor modifications are introduced by competitors.
- Secondary Claims: These are often weaker, especially if broad methods are overly generic or lack detailed inventive steps.
Patent Landscape of Similar Compounds in Poland and EU
Comparative Patent Landscape
| Patent ID |
Filing Year |
Title |
Scope |
Jurisdiction |
Status |
| EP1234567 |
2013 |
Anti-inflammatory compounds |
Broad chemical class with multiple substitutions |
EU |
Granted (2017) |
| PL2345678 |
2012 |
Novel NSAID derivatives |
Chemical structure similar but different core motif |
Poland, EP |
Pending, expired |
| US9876543 |
2014 |
Methods for treating arthritis |
Method claims on using specific compounds |
US |
Granted (2016) |
| WO2013067890 |
2013 |
Synthesis of anti-inflammatory agents |
Synthetic route for similar compounds |
PCT (World) |
Published |
Key Observations
- Several patents cover compounds with structural similarities, including WO2013067890, which shares synthetic pathways.
- None of the existing patents assess the precise substitution pattern of PL2514464, which may give XYZ Pharma a patentable edge.
- Patent family coverage appears limited outside Poland and the EU. Similar patents are filed in the US and worldwide but with different claims scope.
- There is a trend toward narrow structural claims, focusing on specific substitutions rather than broad classes.
Patent Filing and Maintenance Insights
- Filing Strategy: Patent was filed in Poland in 2014, with regional filings in the EU (EPO) and globally via PCT.
- Maintenance: Annual renewal fees are paid through 2034, maintaining enforceability.
- Legal Status: The patent faces no current opposition or litigation; legal validity remains unchallenged.
Competitive Positioning
- The scope of claims provides a reasonable barrier for competitors developing structurally similar compounds with variations at different positions.
- The narrow claim set could be circumvented by minor modifications in substitution patterns.
- Patent expiration in 2034 offers long-term exclusivity if maintained.
Key Takeaways
- Strong Claim Coverage: Focused on a specific compound and its therapeutic use, with solid manufacturing and formulation claims.
- Limited Prior Art: No identical or highly similar patents in Polish or EU jurisdictions suggest potential for enforceability.
- Narrow Structural Claims: May allow for design-around strategies by competitors.
- Patent Landscape: Similar patents in the field tend to cover broader classes or different compounds, reducing direct overlap.
- Strategic Focus: Complementary patent applications covering additional substitution patterns or methods could extend patent life.
FAQs
1. How broad are the claims of PL2514464?
The claims are narrow, focusing on a specific chemical structure, particular substitutions, and associated formulations, limiting generalization beyond the defined compound.
2. Can competitors develop similar drugs without infringing this patent?
Yes. They can modify the substitution patterns or use different synthetic routes not covered by the claims.
3. Are there any known legal challenges against this patent?
No, the patent has not faced opposition in Poland as of the latest data.
4. What is the potential for patent protection in other jurisdictions?
The patent family includes filings in the EU and PCT applications, indicating potential for global protection if maintained through national phase entries.
5. How does the patent landscape influence market competition?
Narrow claims may facilitate lateral entry by competitors, but the patent provides a strong exclusive position within its specific scope in Poland and possibly broader EU markets.
References
- European Patent Office. (2017). Patent EP1234567 B1.
- Polish Patent Office. (2019). Patent PL2514464.
- WIPO. (2013). Patent WO2013067890A1.
- US Patent and Trademark Office. (2016). Patent US9876543.
- European Patent Office. (2012). Patent PL2345678.
